Accounting for biological assets reflects chosen methods, not intrinsic biological qualities
Evidence
Accounting for assets, in general, is not an objective or neutral measure of some latent or inherent quality of biology itself. Any analysis of value in the bio-economy has to look at a range of valuation methods—for example, asset, income, or market approaches (e.g., Bratic, Blok, and Gostola 2014)—as well as different valuation expectations. — Kean Birch, Rethinking Value in the Bio-economy, 78
Categorization
- XREF: Parallels the reader’s existing work on trees as underused infrastructure, which treats biological assets as mattering rather than inert. — connects to: Accounting practices involve interpretation and are not straightforwardly performative — Kean Birch, Rethinking Value in the Bio-economy:…, 35; In the bioeconomy, informational signaling about assets, not product sales, constitutes firm value. — Kean Birch, Rethinking Value in the Bio-economy:…, 106; Sustainability accounting quantifies some impacts while obscuring hard-to-measure ones — Gerald F. Davis & Suntae Kim, Financialization of the Economy, 88 (+3 more)
Related
- Analyzing bio-economy value requires focusing on assets rather than commodities (similarity 0.86)
- Asset value is constituted by active management within organizations, not by biological properties. (similarity 0.85)
- Value in the bio-economy is managed through asset governance, not product sales. (similarity 0.85)
- Value in the bio-economy is produced through valuation practices, not intrinsic to biological matter. (similarity 0.84)
- Bio-economy valuation practices are not peculiar to that sector. (similarity 0.84)
- Accounting practices involve interpretation and are not straightforwardly performative (similarity 0.84)
- Understanding value requires studying the assets underpinning firm valuation, not commodity production. (similarity 0.84)
- Value in the bio-economy is better theorized through assetization than commodification. (similarity 0.84)
- In the bioeconomy, informational signaling about assets, not product sales, constitutes firm value. (similarity 0.82)
- Asset value derives from future earnings rather than intrinsic commodity value (similarity 0.82)
- Value is constituted by knowledge and practice, not merely hype. (similarity 0.80)
- Asset value is actively managed, including downward, and its constructedness is obscured. (similarity 0.80)
- Value is not inherent in things but achieved through capitalization practices. (similarity 0.79)
- Life sciences firms may never produce products, so valuation is prospective rather than embodied (similarity 0.79)
- Capitalization builds the thing being valued at the same time it appraises that thing (similarity 0.79)
Broader Connections
- Production budgets signal value independent of any real meaning in products
#corroborates(0.85) - Value emerges from relational valuation practices, not from objects themselves.
#corroborates(0.85) — Ève Chiapello, Financialisation of Valuation, 23 - In the bioeconomy, informational signaling about assets, not product sales, constitutes firm value.
#expands(0.80) — Kean Birch, Rethinking Value in the Bio-economy, 106 - Sustainability accounting quantifies some impacts while obscuring hard-to-measure ones
#exemplifies(0.80) — Gerald F. Davis & Suntae Kim, Financialization of the Economy, 88 - Asset value derives from future earnings rather than intrinsic commodity value
#qualifies(0.72) — Kean Birch, Rethinking Value in the Bio-economy, 73